Literature DB >> 24029423

Patient-specific prediction of ESRD after liver transplantation.

Pratima Sharma1, Nathan P Goodrich, Douglas E Schaubel, Mary K Guidinger, Robert M Merion.   

Abstract

Incident ESRD after liver transplantation (LT) is associated with high post-transplant mortality. We constructed and validated a continuous renal risk index (RRI) to predict post-LT ESRD. Data for 43,514 adult recipients of deceased donor LT alone (February 28, 2002 to December 31, 2010) were linked from the Scientific Registry of Transplant Recipients and the Centers for Medicare and Medicaid Services ESRD Program. An adjusted Cox regression model of time to post-LT ESRD was fitted, and the resulting equation was used to calculate an RRI for each LT recipient. The RRI included 14 recipient factors: age, African-American race, hepatitis C, cholestatic disease, body mass index ≥ 35, pre-LT diabetes, ln creatinine for recipients not on dialysis, ln albumin, ln bilirubin, serum sodium<134 mEq/L, status-1, previous LT, transjugular intrahepatic portosystemic shunt, and acute dialysis at LT. This RRI was validated and had a C statistic of 0.76 (95% confidence interval, 0.75 to 0.78). Higher RRI associated significantly with higher 5-year cumulative incidence of ESRD and post-transplant mortality. In conclusion, the RRI constructed in this study quantifies the risk of post-LT ESRD and is applicable to all LT alone recipients. This new validated measure may serve as an important prognostic tool in ameliorating post-LT ESRD risk and improve survival by informing post-LT patient management strategies.

Entities:  

Mesh:

Year:  2013        PMID: 24029423      PMCID: PMC3839556          DOI: 10.1681/ASN.2013040436

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  Impact of MELD-based allocation on end-stage renal disease after liver transplantation.

Authors:  P Sharma; D E Schaubel; M K Guidinger; N P Goodrich; A O Ojo; R M Merion
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

Review 2.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

3.  Risk factors for end-stage kidney disease after pediatric liver transplantation.

Authors:  R L Ruebner; P P Reese; M R Denburg; E B Rand; P L Abt; S L Furth
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

4.  Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study.

Authors:  K Boudjema; C Camus; F Saliba; Y Calmus; E Salamé; G Pageaux; C Ducerf; C Duvoux; C Mouchel; A Renault; P Compagnon; R Lorho; E Bellissant
Journal:  Am J Transplant       Date:  2011-04-05       Impact factor: 8.086

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.

Authors:  Pratima Sharma; Nathan P Goodrich; Min Zhang; Mary K Guidinger; Douglas E Schaubel; Robert M Merion
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

7.  Transplant data: sources, collection, and caveats.

Authors:  David M Dickinson; Paula C Bryant; M Christian Williams; Gregory N Levine; Shiqian Li; James C Welch; Berkeley M Keck; Randall L Webb
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

8.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

9.  Chronic renal failure after transplantation of a nonrenal organ.

Authors:  Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

10.  Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

Authors:  P De Simone; F Nevens; L De Carlis; H J Metselaar; S Beckebaum; F Saliba; S Jonas; D Sudan; J Fung; L Fischer; C Duvoux; K D Chavin; B Koneru; M A Huang; W C Chapman; D Foltys; S Witte; H Jiang; J M Hexham; G Junge
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

View more
  17 in total

Review 1.  Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.

Authors:  Pratima Sharma; Khurram Bari
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

2.  Predictors of Early Hospitalization After Deceased Donor Liver Transplantation.

Authors:  Jessica Yu; Amy Hosmer; Tamara Parks; Christopher J Sonnenday; Pratima Sharma
Journal:  Dig Dis Sci       Date:  2015-06-30       Impact factor: 3.199

3.  National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.

Authors:  Pratima Sharma; Nathan P Goodrich; Douglas E Schaubel; Abigail R Smith; Robert M Merion
Journal:  Liver Transpl       Date:  2017-09       Impact factor: 5.799

4.  Risk factors for new-onset chronic kidney disease in patients who have received a liver transplant.

Authors:  Yuehong Li; Binbin Li; Wei Wang; Jiaxuan Lv
Journal:  Exp Ther Med       Date:  2018-01-31       Impact factor: 2.447

5.  National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation.

Authors:  Nathan P Goodrich; Douglas E Schaubel; Abigail R Smith; Robert M Merion; Pratima Sharma
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

Review 6.  Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.

Authors:  J Levitsky; J G O'Leary; S Asrani; P Sharma; J Fung; A Wiseman; C U Niemann
Journal:  Am J Transplant       Date:  2016-04-22       Impact factor: 8.086

7.  Renal Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US Multicenter Simultaneous Liver-Kidney Transplantation Consortium.

Authors:  Pratima Sharma; Zhiyu Sui; Min Zhang; John C Magee; Pranab Barman; Yuval Patel; Aaron Schluger; Kara Walter; Scott W Biggins; Giuseppe Cullaro; Randi Wong; Jennifer C Lai; Jennifer Jo; Jasmine Sinha; Lisa VanWagner; Elizabeth C Verna
Journal:  Liver Transpl       Date:  2021-04-21       Impact factor: 6.112

8.  Posttransplant Hyponatremia Predicts Graft Failure and Mortality in Kidney Transplantation Recipients: A Multicenter Cohort Study in Korea.

Authors:  Seung Seok Han; Miyeun Han; Jae Yoon Park; Jung Nam An; Seokwoo Park; Su-Kil Park; Duck-Jong Han; Ki Young Na; Yun Kyu Oh; Chun Soo Lim; Yon Su Kim; Young Hoon Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

9.  Liberation From Renal Replacement Therapy After Cadaveric Liver Transplantation.

Authors:  Ibtesam A Hilmi; Ali Al-Khafaji; Daniela Damian; Bedda L Rosario-Rivera; Ali Abdullah; John A Kellum
Journal:  Transplant Direct       Date:  2016-10-10

10.  SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL.

Authors:  Bekir Tanriover; Malcolm P MacConmara; Justin Parekh; Cristina Arce; Song Zhang; Ang Gao; Arjmand Mufti; Swee-Ling Levea; Burhaneddin Sandikci; Mehmet U S Ayvaci; Venketash K Ariyamuthu; Christine Hwang; Sumit Mohan; Mutlu Mete; Miguel A Vazquez; Jorge A Marrero
Journal:  Kidney Int Rep       Date:  2016-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.